ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2604

Evaluation of Serum Undercarboxylated Osteocalcin in Premenopausal Rheumatoid Arthritis Patients; Its Correlation with Disease Activity and Bone Mineral Density

Heba Esaily1, Abd El Samad Al Hewala2, Samar Soliman3, Eman Galbat4 and Dalia Abo Al- Ela5, 1Physical Medicine and Rehabilitation,, Faculty of Medicine, Menoufia University, Menofia, Egypt, 2Department of Rheumatology, Faculty of Medecine, Zagazigue University, Al Sharquia, Egypt, 3Physical Medicine and Rehabilitation, Faculty of Medicine, Menoufia University, Menoufia,, Egypt, 4Physical Medicine and Rehabilitation, Faculty of Medicine, Menoufia University, Menoufia, Egypt, 5Clinical Pathology, Faculty of Medicine, Menoufia University, Menofia, Egypt

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Disease Activity, Osteoporosis and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

The role of vitamin K and undercarboxylated osteocalcin (ucOC) on BMD in RA is present. Up to our knowledge no other works have discussed the relationship between ucOC and BMD in premenopausal RA patients and its correlation with disease activity.

Methods:

Sixty Premenopausal rheumatoid arthritis female patients and thirty healthy premenopausal controls with matched age were included in this study.All were subjected to demographic data , clinical examination, Laboratory investigations:-including serum level of ucOC, disease activity assessment by DAS 28 score and  bone mineral density measurement in the lumbar spine L2–4 ,hip and distal radius by dual-energy X-ray absorptimetry (DEXA) equipment. 

Results:

In our study the  level of ucOC was significantly higher in  patients  of RA than controls (p <0.001 ). BMD in patients was found to be significantly lower than controls in spine,femoral neck and distal radius  areas. The  most frequent osteoporotic site according to Z score was  spine(16.7%) followed by femoral neck (8.3 %) then distal radius  (6.7%).While  the commonest osteopenic site according to (Z score ≤ -1) was spine(31.7%)  followed by femoral neck (21.7 %)then (16.7% )in the distal radius. Our work showed that ucOC level was found to be high in premenopausal RA patients with higher DAS values than those with lower DAS value (p<0.001) . In our work BMD measured by DEXA scan was found to be lower with higher DAS values and vice versa. 

Conclusion:

Serum level of ucOC (which is amirror of vitamin K defficency ) was found to be higher in premenopausal RA patients than control and correlated positively with disease activity and inversely with BMD measurement.


Disclosure: H. Esaily, None; A. E. S. Al Hewala, None; S. Soliman, None; E. Galbat, None; D. Abo Al- Ela, None.

To cite this abstract in AMA style:

Esaily H, Al Hewala AES, Soliman S, Galbat E, Abo Al- Ela D. Evaluation of Serum Undercarboxylated Osteocalcin in Premenopausal Rheumatoid Arthritis Patients; Its Correlation with Disease Activity and Bone Mineral Density [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/evaluation-of-serum-undercarboxylated-osteocalcin-in-premenopausal-rheumatoid-arthritis-patients-its-correlation-with-disease-activity-and-bone-mineral-density/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-serum-undercarboxylated-osteocalcin-in-premenopausal-rheumatoid-arthritis-patients-its-correlation-with-disease-activity-and-bone-mineral-density/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology